SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001104659-16-154928
Filing Date
2016-11-04
Accepted
2016-11-04 16:34:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 F-3/A a16-20255_3f3a.htm F-3/A 118585
2 EX-5.1 a16-20255_3ex5d1.htm EX-5.1 77501
  Complete submission text file 0001104659-16-154928.txt   197015
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-214197 | Film No.: 161975602
SIC: 2834 Pharmaceutical Preparations